Federal Trade Commission Cracks Down On Unproven COVID-19 Treatment

The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the non-approved drug, thymosin alpha-1, were first reported by NPR.
(Image credit: Alex Brandon/AP)
